NEW YORK (AP) -- A federal judge Thursday blocked a Canadian company from selling more of its generic version of blood thinner Plavix, finding it unlikely that the manufacturer could prove that the patent on the drug used by 48 million Americans was invalid.
U.S. District Judge Sidney H. Stein in Manhattan issued his written ruling Thursday after a two-day hearing in which Sanofi-Aventis and partner Bristol-Myers Squibb Co. insisted the Canadian company, Apotex Inc., must be forced to stop selling its product.
Comments
Use the comment form below to begin a discussion about this content.